Skip to main content

ADVERTISEMENT

Steven Kymes, PhD

Background: Treatment-resistant schizophrenia (TRS), defined as schizophrenia not responding to two trials of antipsychotics (APs) of adequate dose and duration, affects about one-third o...
03/01/2019